药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Flurandrenolide
Ajmaline
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Ajmaline.
Flurandrenolide
Arformoterol
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Arformoterol.
Flurandrenolide
Lapatinib
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Lapatinib.
Flurandrenolide
Encainide
The risk or severity of QTc prolongation can be increased when Encainide is combined with Chlorprothixene.
Flurandrenolide
Cilostazol
The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Chlorprothixene.
Flurandrenolide
Bretylium
The risk or severity of QTc prolongation can be increased when Bretylium is combined with Chlorprothixene.
Flurandrenolide
Perhexiline
The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Chlorprothixene.
Flurandrenolide
Gatifloxacin
The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Chlorprothixene.
Flurandrenolide
Salbutamol
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Chlorprothixene.
Flurandrenolide
Ketotifen
The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Chlorprothixene.
Flurandrenolide
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Chlorprothixene.
Flurandrenolide
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Chlorprothixene.
Flurandrenolide
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Chlorprothixene.
Flurandrenolide
Terbutaline
The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Chlorprothixene.
Flurandrenolide
Lofexidine
The therapeutic efficacy of Chlorprothixene can be increased when used in combination with Lofexidine.
Flurandrenolide
Secretin human
The therapeutic efficacy of Secretin human can be decreased when used in combination with Chlorprothixene.
Flurandrenolide
Deutetrabenazine
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Deutetrabenazine.
Flurandrenolide
Tetrabenazine
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Tetrabenazine.
Flurandrenolide
Pitolisant
The therapeutic efficacy of Pitolisant can be decreased when used in combination with Chlorprothixene.
Flurandrenolide
Delamanid
Chlorprothixene may increase the QTc-prolonging activities of Delamanid.